Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.

about

Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.

Item

http://www.wikidata.org/entity/Q55114129

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Use of adjuvant chemotherapy i ...... ico: A population-based study.

@en

Use of adjuvant chemotherapy i ...... ico: A population-based study.

@nl

type

Item

label

Use of adjuvant chemotherapy i ...... ico: A population-based study.

@en

Use of adjuvant chemotherapy i ...... ico: A population-based study.

@nl

prefLabel

Use of adjuvant chemotherapy i ...... ico: A population-based study.

@en

Use of adjuvant chemotherapy i ...... ico: A population-based study.

@nl

P1476

Use of adjuvant chemotherapy i ...... ico: A population-based study.

@en

P2093

Alejandro Veintidós-Feliú

http://www.w3.org/2001/XMLSchema#string

Carlos R Torres-Cintrón

http://www.w3.org/2001/XMLSchema#string

Karen J Ortiz-Ortiz

http://www.w3.org/2001/XMLSchema#string

Priscilla Magno

http://www.w3.org/2001/XMLSchema#string

Robert Hunter-Mellado

http://www.w3.org/2001/XMLSchema#string

Ruth Ríos-Motta

http://www.w3.org/2001/XMLSchema#string

Tonatiuh Suárez-Ramos

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised co

Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer

Development of a comorbidity index using physician claims data.

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Effects of type of health insurance coverage on colorectal cancer survival in Puerto Rico: a population-based study.

Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.

Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses

P304

e0194415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0194415

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guillermo Tortolero-Luna

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29584752

http://www.w3.org/2001/XMLSchema#string

P932

5870969

http://www.w3.org/2001/XMLSchema#string